More than 30 branded biomedicals with sales of $51 billion are set to lose patent exclusivity in the next five years, allowing for an uptake of biosimilar versions which can drive market growth. (Datamonitor)
Over 400 biotech drug products and vaccines are currently in clinical trials in attempts to target and treat over 200 diseases, such as cancers, Alzheimer’s disease, heart disease, diabetes, multiple sclerosis, AIDS, and arthritis. (BIO)
Over 1.42 million American were employed by the bioscience sector in 2008, an increase of 19,000 jobs since 2007.
